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Calmodulin-Like Protein Upregulates Myosin-10 in
Human Keratinocytes and Is Regulated during
Epidermal Wound Healing In Vivo
Richard D. Bennett1,2,4, Amy S. Mauer1, Mark R. Pittelkow1,3 and Emanuel E. Strehler1
Epidermal wound healing is required for normal skin barrier function. Cell motility is a key factor in the ability
of keratinocytes to heal epithelial damage. Calmodulin-like protein (CLP) is an epithelial-specific Ca2þ -binding
protein that is regulated during terminal keratinocyte differentiation. CLP is a specific light chain of
unconventional myosin-10 (Myo10) and its expression increases filopodial length, filopodial number, and
Myo10-dependent cell motility in vitro. However, the effects of CLP expression on keratinocyte motility are
unknown. Here we used cultured human keratinocytes to study the role of CLP in regulating Myo10 and the
effects of Myo10 and CLP on cell migration. CLP and Myo10 expression were correlated in vitro and required for
keratinocyte motility in wound-healing assays. We examined the localization of CLP in wounded skin by
immunohistochemistry and found an upregulation and peripheral localization of CLP in the basal and
suprabasal cells adjacent to and immediately over the wound bed in vivo. The results suggest that increased
CLP expression and CLP-mediated Myo10 function are important for skin differentiation and wound
reepithelialization.
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INTRODUCTION
For skin to perform its essential role as a barrier to external
insult and dehydration it must be able to repair injuries
efficiently and effectively. The process of wound healing has
been extensively reviewed (Steffensen et al., 2001; Lans-
down, 2002; Yates and Rayner, 2002; Kirfel and Herzog,
2004; Yamaguchi et al., 2005; Sivamani et al., 2007; Werner
et al., 2007). Immediately after wounding, keratinocytes enter
a preparative phase lasting between 18 and 24 hours when
they disassemble intercellular desmosomes (and hemidesmo-
somes; Yates and Rayner, 2002). The release of signaling
molecules (as a result of damage and inflammation) and other
growth factors stimulates keratinocytes surrounding the
wound to detach from each other and the basement
membrane and begin a phase of migration and proliferation
to cover the wound bed and begin synthesis of a new
basement membrane (Eming et al., 2007). The wound then
enters a remodeling and normalization phase where newly
established basal keratinocytes produce full thickness epi-
dermis (Santoro and Gaudino, 2005; Sivamani et al., 2007).
To initiate this phase, the cells change morphology and, at
the wound edge, produce lamellipodia and filopodia that
project toward the wound, likely following chemotactic
signals from cytokines and a Ca2þ chemical gradient
(Lansdown, 2002). Keratinocytes near the wound edge
migrate by pulling themselves along a provisional substrate
of fibronectin, integrins, and collagen and invade under the
established eschar by secreting matrix metalloproteinases and
plasminogen activator (Steffensen et al., 2001). Keratinocytes
immediately behind the wound front enter a proliferative
phase to ensure an adequate supply of cells. Once contact
inhibited, newly resurfaced epidermal keratinocytes attach to
the underlying extracellular matrix and begin to reconstitute a
basement membrane, followed by rapid terminal differentia-
tion and tissue remodeling to recreate an impermeable
barrier (Sivamani et al., 2007).
Calcium plays an integral role in the wound-healing
response (Lansdown, 2002). In normal skin a Ca2þ gradient
exists from the basal to granular layers, with highest
concentrations of Ca2þ in the upper layers of cells (Pillai
et al., 1993; Vicanova et al., 1998). Ca2þ also forms a
gradient in wounded skin. It is thought that keratinocytes
display a chemotactic response to the Ca2þ gradient
established in the wound (Trump et al., 1984; Magee et al.,
1987). In response to Ca2þ elevation, keratinocytes express
various Ca2þ -binding proteins such as calmodulin-like
protein (CLP) and calmodulin-like skin protein, which
increase in abundance during in vitro differentiation and
are expressed in a pattern matching the observed Ca2þ
& 2009 The Society for Investigative Dermatology www.jidonline.org 765
ORIGINAL ARTICLE
Received 28 February 2008; revised 6 August 2008; accepted 7 August 2008;
published online 25 September 2008
1Department of Biochemistry and Molecular Biology, Mayo Clinic College of
Medicine, Rochester, Minnesota, USA; 2Cell Biology and Genetics Program,
Mayo Graduate School, Rochester, Minnesota, USA and 3Department of
Dermatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Correspondence: Dr Emanuel E. Strehler, Department of Biochemistry and
Molecular Biology, Mayo Clinic College of Medicine, 200 First Street SW,
Rochester, Minnesota 55905, USA. E-mail: strehler.emanuel@mayo.edu
4Current address: McLaughlin Research Institute, Great Falls, Montana, USA.
Abbreviations: CLP, calmodulin-like protein; Myo10, myosin-10
gradient (Pillai et al., 1993; Me´hul et al., 2001; Rogers et al.,
2001).
CLP is a specific light chain of unconventional myosin-10
(Myo10) and was recently shown to upregulate Myo10
function in HeLa cells (Bennett et al., 2007). Myo10 is
essential for filopodial extension in directional cell move-
ment, but is also important for cell attachment and spreading,
among its multiple functions (Berg et al., 2000; Berg and
Cheney, 2002; Yonezawa et al., 2003; Tokuo and Ikebe,
2004; Zhang et al., 2004; Bohil et al., 2006; Toyoshima and
Nishida, 2007). Myo10 transports integrins, which are
regulated during keratinocyte migration in the processes of
wound repair (Adams and Watt, 1991; Kirfel and Herzog,
2004; Zhang et al., 2004). These data suggest that CLP may
be regulated in skin to enhance Myo10 function in cell
attachment, migration, and cell signaling. It is, therefore, of
interest to examine the functional role of CLP expression in
keratinocytes and explore the role of CLP and Myo10 in
keratinocyte migration. In this study we used cultured
keratinocytes to show the effect of endogenous and
exogenous CLP expression on Myo10. We examined the
role of CLP and Myo10 in keratinocyte motility in vitro and
followed the expression of CLP during wound reepithelializa-
tion. Our data indicate a physiological role for CLP in human
epidermis that is likely mediated by Myo10.
RESULTS
CLP and Myo10 are coordinately regulated in keratinocytes
We have previously shown that keratinocytes in culture
upregulate CLP mRNA to highest levels by 4 days postcon-
fluence (Rogers et al., 2001). We found that protein levels
closely follow the mRNA and reach a maximal level by 3–4
days postconfluence (Figure 1a, middle panel). Importantly,
Myo10 levels also increase during in vitro keratinocyte
differentiation and reach elevated levels around day 4
postconfluence (Figure 1a, top panel). To determine the
connection between CLP and Myo10 expression, we
transiently transfected subconfluent keratinocytes (which
express virtually no endogenous CLP) with a CLP expression
vector and analyzed the CLP and Myo10 expression levels
24–48 hours later. As shown in Figure 1b, exogenous
expression of CLP resulted in a concomitant increase of
Myo10 levels in these keratinocytes. This upregulation of
Myo10 by CLP is not because of increased Myo10 transcrip-
tion but rather due to enhanced Myo10 translation and
stabilization, as previously observed (Bennett et al., 2007;
Bennett and Strehler, 2008).
Myo10 is expressed at the cell periphery in keratinocytes
Immunohistochemical staining of normal skin tissue sections
showed that CLP follows a polarized pattern of expression as
previously reported (Rogers et al., 2001). CLP staining is
present exclusively in the epidermis and increases in intensity
from the basal to granular layers (Figure 2a). In the granular
layer, cell nuclei are often intensely positive for CLP, as
previously noted (Rogers et al., 2001). Because the available
anti-Myo10 antibodies are not suitable for immunostaining of
paraffin-embedded tissue sections, we used cultured kerati-
nocytes for immunofluorescence staining with anti-Myo10
antibody. Myo10 was present throughout the cell and
accumulated in distinct puncta within filopodial tips and at
the cell periphery (Figure 2b) as has previously been observed
in other cell types (Berg and Cheney, 2002; Tokuo and Ikebe,
2004; Bohil et al., 2006; Bennett et al., 2007).
Knockdown of CLP or Myo10 equally inhibits keratinocyte
motility in vitro
Keratinocytes are ‘‘professional’’ wound healers that effi-
ciently migrate to close an open wound. Myo10 has been
implicated in cell motility and specifically concentrates at the
leading edge of migrating cells where it is involved in
filopodial extension and associated with dynamic actin
remodeling processes (Tokuo and Ikebe, 2004; Bohil et al.,
2006). We recently showed that CLP enhances Myo10
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Figure 1. CLP and Myo10 expression are correlated. (a) Western blot
showing Myo10 and CLP expression during keratinocyte differentiation
in vitro. Confluent keratinocyte cultures were stimulated to undergo terminal
differentiation by the addition of 1.2mM CaCl2 to the medium and
withdrawing growth factors. Cells were lysed at the indicated time (days
postconfluence) and proteins separated by SDS–PAGE before western blotting
for Myo10 (top), CLP (middle), and GAPDH (as loading control). (b)
Representative western blot of subconfluent (undifferentiated) keratinocytes
either untransfected (, control) or transiently transfected with a CLP
expression vector (TO-CLP, þ ) and probed for Myo10, CLP, and GAPDH.
ActinAnti-Myo10
Anti-CLP H & E
Figure 2. CLP expression in normal skin and Myo10 localization to filopodial
tips in keratinocytes. (a) Immunohistochemical detection of CLP in a paraffin
section of normal human skin. The corresponding H&E stained section is
shown on the right. Scale bar¼200 mm. (b) Immunofluorescence staining for
Myo10 (left panel) and actin (Texas-Red phalloidin, right panel) in
keratinocytes grown on glass coverslips. Arrowheads indicate filopodial tip
localization of Myo10. Scale bar¼ 10 mm.
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function in HeLa cells, allowing faster cell migration as well
as more and longer filopodia (Bennett et al., 2007). We
therefore asked if knockdown of CLP or its target protein
Myo10 would negatively affect keratinocyte migration. To
address this, we transfected keratinocytes with siRNA
oligonucleotides against CLP, Myo10, or a negative control,
and performed wound-healing scratch assays as described in
‘‘Materials and Methods’’. Transfection with siRNA achieved
B60–80% knockdown of CLP and Myo10 protein expression
as determined by western blotting, reflecting varying trans-
fection efficiencies (not shown). As illustrated in Figure 3,
downregulation of CLP or Myo10 resulted in a significant
(Pp0.05) decrease in keratinocyte cell migration into a
wound in vitro. Importantly, the inhibition of keratinocyte
wound-healing capacity (by about 30%) was similar for
knockdown of CLP and Myo10, supporting the functional
relationship between these two proteins.
CLP is upregulated in keratinocytes involved in
reepithelialization during normal wound healing
To determine how the CLP expression pattern changes in
response to wounding in vivo, we performed immunohisto-
chemical staining on paraffin sections of normal human skin
wounds (Figure 4). CLP expression was selectively upregu-
lated in the suprabasal and basal layers of keratinocytes
immediately adjacent to the wound edge. Staining for CLP in
these cells shifted from a weak diffuse cytoplasmic and
moderately peripheral staining in the intact skin to an intense
peripheral localization (Figure 4, white arrows in enlarged
inset) in the transition zone close to the wound edge and
overlying the wound bed. This staining pattern is consistent
with the role of CLP as a light chain for Myo10 (Rogers and
Strehler, 2001) and the typical localization of Myo10 in
regions of dynamic actin assembly at the cell periphery. The
increased peripheral CLP staining was consistent throughout
the reepithelializing epidermis, whereas it remained normal
in the epidermis distal to the wound (Figure 4, dark arrows in
composite view).
DISCUSSION
CLP has recently emerged as a new regulator of Myo10
function (Rogers and Strehler, 2001; Bennett et al., 2007).
CLP upregulates the steady-state levels of Myo10 by
enhancing Myo10 synthesis during Myo10 mRNA translation
(Bennett and Strehler, 2008). As a light chain that binds to the
third IQ motif of Myo10, CLP enhances Myo10 function in
filopodial elongation and motility (Bennett et al., 2007). Here
we show that CLP and Myo10 expression are coordinated in
human keratinocytes undergoing differentiation in vitro. The
remarkable change in CLP expression in differentiating
keratinocytes thus suggests the need for an increase in
Myo10-mediated cellular processes in skin development and
regeneration.
For keratinocytes to move, they extend lamellipodia and
filopodia toward the wound and use these structures to drag
themselves into the wound. These thin cellular protrusions
are thought to sense the external environment and serve as
initial attachment sites for the migrating cells. Indeed,
filopodia have been shown to play a crucial role in wound
healing in Drosophila (Wood et al., 2002). Myo10 is essential
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Figure 3. Myo10 and CLP are involved in keratinocyte migration in vitro. (a)
Wound-healing scratch assays to determine keratinocyte migration.
Keratinocytes were transiently transfected with negative control siRNA or
siRNA directed against CLP or Myo10 as indicated. Scratches were made in
confluent monolayers of transfected cells and photographed at time 0 and
4hours later. The contours of the wound edges are outlined to better visualize
the open space. (b) Quantitative analysis of at least three independent scratch
assays as in (a) showing average wound area covered in 4 hours±SD.
*Difference significant at Pp0.05.
Figure 4. CLP is upregulated and shows increased peripheral localization in
basal and suprabasal keratinocytes during wound healing.
Immunohistochemical staining for CLP was performed on paraffin sections of
a healing wound. A composite (tiled) micrograph is shown on the bottom, and
one tile (framed) is shown enlarged on top. CLP staining is increased in basal
and suprabasal cells immediately adjacent to the wound bed (white arrows,
top tile) and concentrated in the cell periphery. Dark arrows in the bottom
micrograph indicate normal epidermis exhibiting regular CLP expression.
Scale bar¼ 200mm.
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for filopodial formation and has been found to directly bind
to and transport integrins to the tips of filopodia for
attachment (Zhang et al., 2004; Bohil et al., 2006). In other
epithelial cell types Myo10 lengthens filopodia in a
fibronectin-dependent manner (Berg and Cheney, 2002).
a5b1 integrins are upregulated in migrating keratinocytes to
bind fibronectin in the wound bed (Larjava et al., 1993;
Breuss et al., 1995; Pullar et al., 2006). Our data show that
Myo10 localizes to filopodial tips and the leading edge in
keratinocytes and that CLP and Myo10 downregulation
equally inhibit keratinocyte migration in a scratch assay.
Furthermore, CLP is upregulated in keratinocytes migrating
into wounds and exhibits strong peripheral localization in
these cells. This distribution likely matches that of Myo10,
which localizes to regions of dynamic actin assembly
typically in the periphery of cells and is involved in filopodial
formation and protrusion.
Taken together, these findings suggest that CLP upregulation
in keratinocytes stimulates Myo10, resulting in increased
Myo10 levels in cells migrating to reepithelialize wounds
in vivo. CLP upregulation may also serve to increase the range
of Myo10 function in areas of high Ca2þ such as those observed
in normal epidermal differentiation and wounded skin.
MATERIALS AND METHODS
Materials
All cell culture media were from Cascade Biologics (Portland, OR).
Protease inhibitors were from Roche (Indianapolis, IN). Dulbecco’s
phosphate buffered saline, precast Nu-PAGE gels, Nu-PAGE MES
running buffer, Lipofectamine-2000 transfection reagents, Stealth
validated siRNA oligonucleotides, Texas-Red –phalloidin, and
transfer stacks for the I-Blot apparatus were from Invitrogen
(Carlsbad, CA). Secondary antibodies for western blotting were from
Santa Cruz (Santa Cruz, CA). Primary antibodies against CLP and
Myo10 were as previously described (Bennett et al., 2007). BCA
protein assays were from Pierce (Rockford, IL). Monoclonal anti-
glyceraldehyde 3-phosphate dehydrogenase antibody was from
Millipore (Billerica, MA). ECLþ Plus western detection reagent was
from GE Healthcare (Piscataway, NJ). Autoradiography film was
from Eastman Kodak (Rochester, NY). All other chemicals were from
Sigma (St. Louis, MO).
Keratinocyte culture
Foreskins discarded after elective circumcisions were collected from
the neonatal unit at Methodist Hospital in Rochester, MN following a
protocol approved by the Mayo Clinic Institutional Review Board.
Keratinocytes were isolated and expanded as previously described
(Wille et al., 1984; Poumay and Pittelkow, 1995) and maintained in
EpiLife medium with human keratinocyte growth supplement
(Cascade Biologics) at 37 1C in a humidified chamber with 5% CO2.
For immunostaining, cells were grown on coverslips and processed for
Myo10 immunofluorescence as previously described (Bennett et al.,
2007). Passage 1 and 2 cultures were stored in liquid nitrogen until
used. Passage 2–5 cultures were used in these experiments.
Transient transfection and western blotting
Keratinocytes were grown in six well plates (Corning, Lowell, MA) to
70% confluence and transfected with 5 mg of the previously
described CLP expression vector TO-CLP (Bennett et al., 2007)
and 10 ml Lipofectamine-2000. After 24–48 hours, cells were
harvested for western blotting as described (Bennett et al., 2007).
Equal amounts of protein were analyzed by denaturing SDS–PAGE
using 4–12% Bis-Tris–HCl Nu-PAGE gels and transferred to PVDF
with Nu-PAGE transfer buffer or using the I-Blot semidry transfer
system (Invitrogen) set for 7-minute transfer. Membranes were then
fixed in 0.2% glutaraldehyde in 25mM K2HPO4 buffer and blocked
for 1 hour in 5% nonfat dry milk in Ca-Tris-buffered saline Tween-20
at room temperature. Blots were then incubated from 2hours at
room temperature to overnight at 4 1C with primary antibody diluted
in Ca-Tris-buffered saline Tween-20. After extensive washing, blots
were incubated in the appropriate secondary antibody conjugated to
horseradish peroxidase, developed with ECLþ Plus reagent, and
exposed to autoradiography film from 3 seconds to 20minutes.
In vitro scratch assay
Wound-healing and cell-motility assays were performed on con-
fluent keratinocyte monolayers as previously described (Bennett
et al., 2007). Briefly, 70% confluent early passage keratinocyte
cultures were transfected with Stealth siRNA (Invitrogen) for CLP
(sequence: AACUACGAGGAGUUUGUCCGU), Myo10 (no.
myo10-HSS106911), or a negative control siRNA (no. 12935–300)
using Lipofectamine-2000 (Invitrogen) following the manufacturer’s
recommendations. Cultures were allowed to reach confluence
(12–24 hours), then wounded with a 10-ml pipette tip and photo-
graphed at regular time intervals. Wound area covered was
measured as described (Bennett et al., 2007). Wound healing was
reported as area of the wound covered over the indicated 4 hours
time interval. Following the final measurement, cells were lysed and
processed for western blotting.
Immunohistochemistry and immunofluorescence
Immunostaining for CLP in tissue sections was performed in the
Mayo Clinic Tissue and Cellular Morphology Analysis core facility.
For CLP, formalin-fixed, paraffin-embedded tissue samples of
wounds from five subjects were obtained from the Mayo Clinic
Tissue registry according to the approved institutional review board
protocol. The sections of 4-mm were processed for immunohisto-
chemistry detection of CLP as previously described (Rogers et al.,
1999, 2001). Immunofluorescence staining for Myo10 was per-
formed on keratinocytes cultured on glass coverslips as described
(Bennett et al., 2007). For actin staining, Texas-Red phalloidin
(Invitrogen, 1:500) was included during incubation with the
secondary antibody. Images were captured using a Nikon Diaphot
epifluorescence microscope (Nikon, Melville, NY) with side-port
mounted Sensicam QE CCD camera (Cooke Corp., Romulus, MI).
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